442 related articles for article (PubMed ID: 26438729)
1. Immunity and immune modulation in Trypanosoma cruzi infection.
Cardillo F; de Pinho RT; Antas PR; Mengel J
Pathog Dis; 2015 Dec; 73(9):ftv082. PubMed ID: 26438729
[TBL] [Abstract][Full Text] [Related]
2. Immune Evasion Strategies of Trypanosoma cruzi.
Flávia Nardy A; Freire-de-Lima CG; Morrot A
J Immunol Res; 2015; 2015():178947. PubMed ID: 26240832
[TBL] [Abstract][Full Text] [Related]
3. The role of Toll-like receptors and adaptive immunity in the development of protective or pathological immune response triggered by the Trypanosoma cruzi protozoan.
Pellegrini A; Guiñazu N; Giordanengo L; Cano RC; Gea S
Future Microbiol; 2011 Dec; 6(12):1521-33. PubMed ID: 22122446
[TBL] [Abstract][Full Text] [Related]
4. Experimental Chagas disease in Balb/c mice previously vaccinated with T. rangeli. II. The innate immune response shows immunological memory: reality or fiction?
Basso B; Marini V
Immunobiology; 2015 Mar; 220(3):428-36. PubMed ID: 25454810
[TBL] [Abstract][Full Text] [Related]
5. [Host immune response to Trypanosoma cruzi and its evasion mechanism].
Yamamoto M; Takeda K
Tanpakushitsu Kakusan Koso; 2009 Jun; 54(8 Suppl):1053-8. PubMed ID: 21089540
[No Abstract] [Full Text] [Related]
6. Trypanosoma cruzi immune evasion mediated by host cell-derived microvesicles.
Cestari I; Ansa-Addo E; Deolindo P; Inal JM; Ramirez MI
J Immunol; 2012 Feb; 188(4):1942-52. PubMed ID: 22262654
[TBL] [Abstract][Full Text] [Related]
7. Experimental Chagas disease. Innate immune response in Balb/c mice previously vaccinated with Trypanosoma rangeli. I. The macrophage shows immunological memory: Reality or fiction?
Basso B; Marini V
Immunobiology; 2014 Apr; 219(4):275-84. PubMed ID: 24321621
[TBL] [Abstract][Full Text] [Related]
8. Evasion of immune responses by Trypanosoma cruzi, the etiological agent of Chagas disease.
DosReis GA
Braz J Med Biol Res; 2011 Feb; 44(2):84-90. PubMed ID: 21243314
[TBL] [Abstract][Full Text] [Related]
9. The endless race between Trypanosoma cruzi and host immunity: lessons for and beyond Chagas disease.
Junqueira C; Caetano B; Bartholomeu DC; Melo MB; Ropert C; Rodrigues MM; Gazzinelli RT
Expert Rev Mol Med; 2010 Sep; 12():e29. PubMed ID: 20840799
[TBL] [Abstract][Full Text] [Related]
10. Innate and acquired immunity in the pathogenesis of Chagas disease.
Golgher D; Gazzinelli RT
Autoimmunity; 2004 Aug; 37(5):399-409. PubMed ID: 15621564
[TBL] [Abstract][Full Text] [Related]
11. [Immune response to Trypanosoma cruzi. An approach to the pathogenesis of Chagas' disease].
Braun M; de Titto E
Acta Physiol Pharmacol Latinoam; 1985; 35(1):1-47. PubMed ID: 2932884
[TBL] [Abstract][Full Text] [Related]
12. The innate immune response to Trypanosoma cruzi infection.
Kayama H; Takeda K
Microbes Infect; 2010 Jul; 12(7):511-7. PubMed ID: 20348008
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of Trypanosoma cruzi persistence in Chagas disease.
Nagajyothi F; Machado FS; Burleigh BA; Jelicks LA; Scherer PE; Mukherjee S; Lisanti MP; Weiss LM; Garg NJ; Tanowitz HB
Cell Microbiol; 2012 May; 14(5):634-43. PubMed ID: 22309180
[TBL] [Abstract][Full Text] [Related]
14. [Role of cytokines in resistance and pathology in Trypanosoma cruzi infection].
Laucella SA; Rottenberg ME; de Titto EH
Rev Argent Microbiol; 1996; 28(2):99-109. PubMed ID: 8768488
[TBL] [Abstract][Full Text] [Related]
15. Molecular basis of Trypanosoma cruzi and Leishmania interaction with their host(s): exploitation of immune and defense mechanisms by the parasite leading to persistence and chronicity, features reminiscent of immune system evasion strategies in cancer diseases.
Ouaissi A; Ouaissi M
Arch Immunol Ther Exp (Warsz); 2005; 53(2):102-14. PubMed ID: 15928579
[TBL] [Abstract][Full Text] [Related]
16. CD8+ T cells in Trypanosoma cruzi infection.
Tarleton RL
Semin Immunopathol; 2015 May; 37(3):233-8. PubMed ID: 25921214
[TBL] [Abstract][Full Text] [Related]
17. Endogenous CD4(+) CD25(+) regulatory T cells have a limited role in the control of Trypanosoma cruzi infection in mice.
Kotner J; Tarleton R
Infect Immun; 2007 Feb; 75(2):861-9. PubMed ID: 17101658
[TBL] [Abstract][Full Text] [Related]
18. Disease Tolerance and Pathogen Resistance Genes May Underlie
Chevillard C; Nunes JPS; Frade AF; Almeida RR; Pandey RP; Nascimento MS; Kalil J; Cunha-Neto E
Front Immunol; 2018; 9():2791. PubMed ID: 30559742
[TBL] [Abstract][Full Text] [Related]
19. The Blockade of Interleukin-2 During the Acute Phase of
Nihei J; Cardillo F; Mengel J
Front Cell Infect Microbiol; 2021; 11():758273. PubMed ID: 34869064
[No Abstract] [Full Text] [Related]
20. Modulation of Intrathymic Sphingosine-1-Phosphate Levels Promotes Escape of Immature Thymocytes to the Periphery with a Potential Proinflammatory Role in Chagas Disease.
Flávia Nardy A; Santos L; Freire-de-Lima CG; Morrot A
Biomed Res Int; 2015; 2015():709846. PubMed ID: 26347020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
